AUM
₹ not available
Benchmark
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them
BSE Healthcare TRI Index
Inception Date
01-07-2025
Expense Ratio (Base)
2.19%
As on 18-07-2025
Historical, annualized average returns, useful for examining the behaviour of returns for a given holding period. For eg: Rolling returns for 5 years are calculated by checking all 5 year time periods across a fund’s history and calculating average/ minimum/ maximum values.
Bars show Return distribution (% of times) in a given range for a selected time period.
This calculator is provided for informational purposes only.
The results are based on user inputs and should not be considered as investment advice. Users should seek the advice of a qualified financial professional before making any investment decisions.
The creators of the calculator and its affiliates shall not be held responsible for any financial losses resulting from the use of the calculator.
Past performance may or may not be sustained in the future and should not be used as a basis for comparison with other investments. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.
SIP is allowed in select open ended schemes. Refer the Scheme SAI, SID, KIM for detailed information
Fund BARODA BNP PARIBAS ELSS Tax Saver Fund - Regular - Growth Option
Frequency Monthly
SIP Start Date 05-01-2006
SIP End Date 01-01-2025
Invested Amount ₹22,80,000.00
Current Value ₹1,03,86,141.98
Scheme Returns 14.17%
Benchmark Returns 14.12%
TER (Total Expense Ratio) 2.2%
This calculator is provided for informational purposes only.
The results are based on user inputs and should not be considered as investment advice. Users should seek the advice of a qualified financial professional before making any investment decisions.
The creators of the calculator and its affiliates shall not be held responsible for any financial losses resulting from the use of the calculator.
Past performance may or may not be sustained in the future and should not be used as a basis for comparison with other investments. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.
SIP is allowed in select open ended schemes. Refer the Scheme SAI, SID, KIM for detailed information
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
Entry Load : Not applicable
Exit Load:
· If units of the Scheme are redeemed or switched out within 1 year from the date of allotment: 1%.
· If units of the Scheme are redeemed or switched out after 1 year from the date of allotment: Nil.
(i) Daily, Weekly, Monthly SIP: ₹ 500/- and in multiples of ₹ 1/- thereafter;
(ii) Quarterly SIP: ₹ 1500/- and in multiples of ₹ 1/- thereafter. There is no upper limit for application.
₹ 1,000/- and in multiples of Re. 1/- thereafter per installment, where an investor opts for a Daily/ weekly/ fortnightly/ monthly STP. ₹ 1,500/- and in multiples of Re. 1/- thereafter per installment, where an investor opts for a quarterly STP. STP will be terminated if the amount to be transferred is less than the minimum application amount of the transferee scheme.
₹ 1,000/- and in multiples of Re. 1/- thereafter per installment, where an investor opts for a weekly/ monthly SWP ₹ 1,500/- and in multiples of Re. 1/- thereafter per installment, where an investor opts for a quarterly SWP
An open ended equity scheme investing in Pharma and Healthcare sector
This product is suitable for investors who are seeking*:
- Long term wealth creation.
- Investment predominantly in equity & equity related instruments of Pharma and Healthcare Companies.
^^Riskometer For Scheme: basis it's portfolio, ^Riskometer For Benchmark (e BSE Healthcare TRI Index): basis it's constituents; as on June 30, 2025
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Sanjay Chawla
Chief Investment Officer Equity (CIO-Equity)
Managing this fund since July 2025
Performance of Other Funds Managed by Sanjay Chawla
An open ended equity scheme investing in Pharma and Healthcare sector
Thematic Equity
| Schemes (Benchmark Index) | 1 Year CAGR | 3 Year CAGR | 5 Year CAGR | |||
|---|---|---|---|---|---|---|
| Scheme Returns | Benchmark Returns | Scheme Returns | Benchmark Returns | Scheme Returns | Benchmark Returns | |
| Baroda BNP Paribas Balanced Advantage Fund (NIFTY 50 Hybrid Composite Debt 50:50 Index) | 8.77% | 8.50% | 18.48% | 13.62% | 17.26% | 13.88% |
| Baroda BNP Paribas ELSS Tax Saver Fund (Nifty 500 TRI) | 6.14% | 5.68% | 22.69% | 21.99% | 21.97% | 24.03% |
| Baroda BNP Paribas Focused Fund (Nifty 500 TRI) | -0.67% | 5.68% | 19.39% | 21.99% | 20.05% | 24.03% |
| Baroda BNP Paribas Large and Mid Cap Fund (BSE 250 Large & Midcap TRI) | 4.69% | 5.29% | 24.22% | 21.00% | N.A.* | N.A.* |
| Baroda BNP Paribas Multi Cap Fund (Nifty 500 Multicap 50:25:25 TRI) | 3.41% | 5.76% | 24.12% | 25.12% | 25.79% | 27.74% |
| Baroda BNP Paribas Flexi Cap Fund (Nity 500 Total Return Index) | 3.92% | 5.68% | N.A.* | 21.99% | N.A.* | 24.03% |
Period for which scheme's performance has been provided is computed basis last day of the month-end preceding the date of advertisement.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Returns do not take into account the load, if any. Returns are for growth option. Different plans shall have a different expense structure. The performance details provided above are for regular/distributor plan.
For Fund Manager(s) & Managing Since Details click here
*Where returns are not available for that particular period, they have not been shown.
© Copyright Baroda BNP Paribas Mutual Fund
SID
KIM